Steffen Mueller

Codagenix: Flu can mutate, but it can’t hide

By GREGORY ZELLER // In a potentially huge breakthrough in the struggle against seasonal influenza mutations, Codagenix Inc. is preparing to release data demonstrating “multi-season efficacy” for its frontline flu vaccine – meaning the vaccine could prevent flu-related sicknesses even after the virus mutates. According to the Farmingdale-based clinical-stage startup, in multiple studies involving pigs and ferrets, CodaVax-H1N1 – Codagenx’s live-attenuated Influenza A vaccine – induced “a robust immune response to multiple seasonal strains of…


Some pig: USDA, Codagenix target swine flu

By GREGORY ZELLER // With Zika virus, Foot and Mouth Disease and other global threats already in its crosshairs, Farmingdale biotech Codagenix Inc. is challenging another high-profile opponent: swine flu. A Phase I Small Business Innovation Research grant from the U.S. Department of Agriculture will fund research and development of an influenza vaccine for swine using Codagenix’s proprietary software platform, which “re-codes” viruses to create and test potential vaccines. Research and development under the $99,710…


Codagenix preps for fight against Zika virus

By GREGORY ZELLER // A Stony Brook startup that digitally recreates viruses in order to reprogram their genomes is preparing to take on the Zika virus, which World Health Organization officials said Thursday is “spreading explosively” through the Americas. Codagenix, a 2012 startup cofounded by Farmingdale State College biology professor J. Robert Coleman and former Stony Brook University assistant research professor Steffen Mueller, is keeping a close eye on the migration of the virus, which…


Codagenix making all the right moves

By GREGOERY ZELLER // A seven-figure Regional Economic Development Council award is set to push an innovative influenza vaccine toward human trials. Codagenix, a 2012 startup cofounded by Farmingdale State College biology professor J. Robert Coleman and former Stony Brook University assistant research professor Steffen Mueller, received $2.25 million through the 2015 REDC awards, which were announced in December. All told, 121 Long Island projects collected $98.3 million through the fifth-annual REDC process, many focused…


With Topspin round, Codagenix steps on the gas

By GREGORY ZELLER // Last year, when local venture firm Topspin chipped in on a $100,000 infusion for Stony Brook-based biotech Codagenix, it gave the startup a fairly clear idea of what to do with the money. “We had suggested to them that they needed to tighten up some aspects of their clinical data, and in fact they used the money to do just that,” said Steve Winick, Topspin’s managing director. “The tests came out…